Profile cover photo
Profile photo
BioSculpture Technology, Inc.
1 follower
1 follower
About
Posts

Post has attachment
BioSculpture Technology's CEO explains the rationale for and potential impact of endoscopic visceral lipectomy
Add a comment...

Post has attachment
BioSculpture Technology, Inc.'s Endoscopic Visceral Lipectomy project.
Add a comment...

Post has attachment
IPO to Develop New Minimally Invasive Obesity & Type 2 Diabetes Treatment
Add a comment...

Post has attachment
BioSculpture Technology's plan to develop EVL to treat Obesity and Type II Diabetes
Add a comment...

Post has attachment
Endoscopic Visceral Lipectomy, a a treatment for Obesity and Type II Diabetes mellitus under development.
Add a comment...

Post has attachment
BioSculpture Technology, Inc. Investor highlights 9/10/16 update
Add a comment...

Post has attachment
Highlights of BioSculpture Technology, Inc.'s Offering and Business plan to develop new minimally invasive treatment of obesity, metabolic syndrome and type 2 diabetes
Add a comment...

Post has attachment
BioSculpture Technology, Inc. files Form 1-A for tier 2 Reg. A. Offering to commercialize its patented endoscopic treatment of obesity and type 2 diabetes.
Add a comment...

Post has attachment
BioSculpture Technology, Inc. Files Form 1-A for Tier 2 Regulation A Offering to commercialize its patented minimally invasive obesity and type 2 diabetes treatment.
Add a comment...

Post has attachment
Endoscopic Visceral Lipectomy as it might be carried out with BioSculpture Technology, Inc.'s EVL® DEVICE.
Add a comment...
Wait while more posts are being loaded